Burton Paul 4
4 · Moderna, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Burton Paul
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+6,505→ 6,505 totalExercise: $149.52From: 2023-03-01Exp: 2032-03-01→ Common Stock (6,505 underlying) - Award
Restricted Stock Units
2022-03-01+1,603→ 1,603 totalExercise: $0.00→ Common Stock (1,603 underlying)
Footnotes (2)
- [F1]25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.